>
//
>
Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.
HIV Testing in Prison: What's the Controversy?
Lancet (12/17/94) Vol. 344, No. 8938, P. 1650
Diamond, Jan
In a Lancet commentary, Jan Diamond of Merrithew Memorial Hospital in Martinez, Calif., wonders whether HIV testing in prisons remains controversial. While the debate during the 1980s focused on mandatory testing for inmates and segregation of those who tested positive, the latest emphasis is on ways to increase voluntary testing and to improve the medical care of infected prisoners. Prison officials contend that protection--of the infected and uninfected inmates and of the correctional staff--is their main concern. The Centers for Disease Control and Prevention (CDC), however, has not found any instances of HIV infection or AIDS in correctional staff due to work-related transmission. Fifteen of the 16 U.S. prisons that conduct mandatory HIV testing do not segregate the HIV-infected inmates, which does not justify claims for any protective efforts. To maximize the effectiveness of voluntary testing and maintain the trust between staff and inmates, HIV testing should be performed by non-correctional staff. Anonymous testing should be considered. Testing must be followed by counseling, education, and good medical care, and interventions known to reduce transmission--such as condom distribution--should be adopted.
941227
AD942312
Copyright © 1994 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. and many more are available free online at --> .